NewGenIvf Group Limited (NASDAQ:NIVF) Sees Large Drop in Short Interest

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a large drop in short interest in the month of December. As of December 31st, there was short interest totaling 13,899 shares, a drop of 93.8% from the December 15th total of 223,462 shares. Currently, 3.4% of the shares of the company are sold short. Based on an average trading volume of 225,239 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 225,239 shares, the days-to-cover ratio is currently 0.1 days. Currently, 3.4% of the shares of the company are sold short.

NewGenIvf Group Stock Performance

NASDAQ NIVF traded down $0.02 during midday trading on Monday, hitting $0.58. The company had a trading volume of 131,985 shares, compared to its average volume of 197,108. The firm has a fifty day simple moving average of $1.37 and a two-hundred day simple moving average of $7.59. NewGenIvf Group has a fifty-two week low of $0.56 and a fifty-two week high of $1,907.50. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.37 and a current ratio of 3.43.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on NIVF. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a report on Friday, October 31st. Wall Street Zen upgraded NewGenIvf Group to a “hold” rating in a research note on Saturday, December 6th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.